TABLE 1.
Peak # | Identityb | Distribution of 35S-apoA-I Labela
|
|
---|---|---|---|
(−) cAMP | (+) cAMP | ||
% | |||
1 | Intact 35S-apoA-I | 73 (164 ng) | 24 (54 ng) |
2 | Degraded (TCA soluble) 35S label | 15 (34 ng) | 27 (61 ng) |
3 | Intact 35S-apoA-I in cholesterol-containing particles | 8 (18 ng) | 48 (108 ng) |
Totalc | 96 | 99 |
apoA-I, apolipoprotein A-I.
The percent distribution of label from the column runs shown in Fig. 5 was determined by summing the total counts in each fraction. For each experiment, peak 1 was defined as fractions 19–24, peak 2 as fractions 30–36, and peak 3 as fractions 10–18. The percent distribution is shown, along with the approximate mass of apoA-I that would be associated with each peak, given that 2,250 ng of apoA-I was initially used in the incubation (see Discussion)
The state of apoA-I (intact, degraded, lipidated, etc.) was determined by Western blot analysis, TCA precipitation, and cofractionation with cholesterol as described in Results.
The total did not add up to 100%, because there were small amounts of counts present in fractions that were not included in the three major peaks.